Effect of insulin-induced hypoglycaemia on the central nervous system: evidence from experimental studies

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Effect of insulin-induced hypoglycaemia on the central nervous system : evidence from experimental studies. / Jensen, Vivi Flou Hjorth; Bøgh, I. B.; Lykkesfeldt, Jens.

In: Journal of Neuroendocrinology, Vol. 26, No. 3, 2014, p. 123-150.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Jensen, VFH, Bøgh, IB & Lykkesfeldt, J 2014, 'Effect of insulin-induced hypoglycaemia on the central nervous system: evidence from experimental studies', Journal of Neuroendocrinology, vol. 26, no. 3, pp. 123-150. https://doi.org/10.1111/jne.12133

APA

Jensen, V. F. H., Bøgh, I. B., & Lykkesfeldt, J. (2014). Effect of insulin-induced hypoglycaemia on the central nervous system: evidence from experimental studies. Journal of Neuroendocrinology, 26(3), 123-150. https://doi.org/10.1111/jne.12133

Vancouver

Jensen VFH, Bøgh IB, Lykkesfeldt J. Effect of insulin-induced hypoglycaemia on the central nervous system: evidence from experimental studies. Journal of Neuroendocrinology. 2014;26(3):123-150. https://doi.org/10.1111/jne.12133

Author

Jensen, Vivi Flou Hjorth ; Bøgh, I. B. ; Lykkesfeldt, Jens. / Effect of insulin-induced hypoglycaemia on the central nervous system : evidence from experimental studies. In: Journal of Neuroendocrinology. 2014 ; Vol. 26, No. 3. pp. 123-150.

Bibtex

@article{f7a52de806674c6ab9a81e7f25074762,
title = "Effect of insulin-induced hypoglycaemia on the central nervous system: evidence from experimental studies",
abstract = "Insulin-induced hypoglycaemia (IIH) is a major acute complication in type 1 as well as in type 2 diabetes, particularly during intensive insulin therapy. The brain plays a central role in the counter-regulatory response by eliciting parasympathetic and sympathetic hormone responses to restore normoglycaemia. Brain glucose concentrations, being approximately 15-20{\%} of the blood glucose concentration in humans, are rigorously maintained during hypoglycaemia through adaptions such as increased cerebral glucose transport, decreased cerebral glucose utilisation and, possibly, by using central nervous system glycogen as a glucose reserve. However, during sustained hypoglycaemia, the brain cannot maintain a sufficient glucose influx and, as the cerebral hypoglycaemia becomes severe, electroencephalogram changes, oxidative stress and regional neuronal death ensues. With particular focus on evidence from experimental studies on nondiabetic IIH, this review outlines the central mechanisms behind the counter-regulatory response to IIH, as well as cerebral adaption to avoid sequelae of cerebral neuroglycopaenia, including seizures and coma.",
keywords = "Faculty of Health and Medical Sciences, insulin, receptors, membrane, binding proteins, glucose transporters",
author = "Jensen, {Vivi Flou Hjorth} and B{\o}gh, {I. B.} and Jens Lykkesfeldt",
note = "{\circledC} 2014 British Society for Neuroendocrinology.",
year = "2014",
doi = "10.1111/jne.12133",
language = "English",
volume = "26",
pages = "123--150",
journal = "Journal of Neuroendocrinology",
issn = "0953-8194",
publisher = "Wiley-Blackwell",
number = "3",

}

RIS

TY - JOUR

T1 - Effect of insulin-induced hypoglycaemia on the central nervous system

T2 - evidence from experimental studies

AU - Jensen, Vivi Flou Hjorth

AU - Bøgh, I. B.

AU - Lykkesfeldt, Jens

N1 - © 2014 British Society for Neuroendocrinology.

PY - 2014

Y1 - 2014

N2 - Insulin-induced hypoglycaemia (IIH) is a major acute complication in type 1 as well as in type 2 diabetes, particularly during intensive insulin therapy. The brain plays a central role in the counter-regulatory response by eliciting parasympathetic and sympathetic hormone responses to restore normoglycaemia. Brain glucose concentrations, being approximately 15-20% of the blood glucose concentration in humans, are rigorously maintained during hypoglycaemia through adaptions such as increased cerebral glucose transport, decreased cerebral glucose utilisation and, possibly, by using central nervous system glycogen as a glucose reserve. However, during sustained hypoglycaemia, the brain cannot maintain a sufficient glucose influx and, as the cerebral hypoglycaemia becomes severe, electroencephalogram changes, oxidative stress and regional neuronal death ensues. With particular focus on evidence from experimental studies on nondiabetic IIH, this review outlines the central mechanisms behind the counter-regulatory response to IIH, as well as cerebral adaption to avoid sequelae of cerebral neuroglycopaenia, including seizures and coma.

AB - Insulin-induced hypoglycaemia (IIH) is a major acute complication in type 1 as well as in type 2 diabetes, particularly during intensive insulin therapy. The brain plays a central role in the counter-regulatory response by eliciting parasympathetic and sympathetic hormone responses to restore normoglycaemia. Brain glucose concentrations, being approximately 15-20% of the blood glucose concentration in humans, are rigorously maintained during hypoglycaemia through adaptions such as increased cerebral glucose transport, decreased cerebral glucose utilisation and, possibly, by using central nervous system glycogen as a glucose reserve. However, during sustained hypoglycaemia, the brain cannot maintain a sufficient glucose influx and, as the cerebral hypoglycaemia becomes severe, electroencephalogram changes, oxidative stress and regional neuronal death ensues. With particular focus on evidence from experimental studies on nondiabetic IIH, this review outlines the central mechanisms behind the counter-regulatory response to IIH, as well as cerebral adaption to avoid sequelae of cerebral neuroglycopaenia, including seizures and coma.

KW - Faculty of Health and Medical Sciences

KW - insulin

KW - receptors

KW - membrane

KW - binding proteins

KW - glucose transporters

U2 - 10.1111/jne.12133

DO - 10.1111/jne.12133

M3 - Journal article

C2 - 24428753

VL - 26

SP - 123

EP - 150

JO - Journal of Neuroendocrinology

JF - Journal of Neuroendocrinology

SN - 0953-8194

IS - 3

ER -

ID: 124441175